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Pore-forming toxins (PFT) form the larg-
est family of secreted toxins from patho-
genic bacteria.1,2  Staphylococcus aureus 
produces different hemolysins, and 
α-hemolysin is one of the well-studied 
PFTs for which the X-ray structure of 
the pore is available.1 These toxins form 
heptameric pores of 1–2 nm in size in 
cell membranes, leading to various out-
comes, including apoptotic cell death, in 
the host cells.2 As epithelial cells and kera-
tinocytes are the major sites of pathogen 
entry, we have set out to investigate the 
molecular machinery driving cell death 
mediated by α-hemolysin in these cell 
types. To our surprise, we have detected 
an initiator caspase role for caspase-2 dur-
ing PFT-mediated apoptosis, and further 
investigations revealed that caspase-2 is 
activated in a PIDDosome-independent 
manner under these conditions.3
Caspases are effector proteases of the 
apoptotic cascade and broadly divided 
into two major classes depending on the 
structure and chronology of their activa-
tion as initiator and effector caspases.4 
Despite being the first mammalian cas-
pases to be cloned and highly conserved, 
the physiological role of this caspase 
remains unclear.5,6 Caspase-2-deficient 
mice develop normally, with mild defects, 
and emerging evidence suggests a role for 
this caspase in regulating DNA damage 
response, cell cycle regulation and tumor 
suppression.6 Like other initiator caspases, 
caspase-2 is activated by dimerization 
mediated through the CARD domains, 
and initial studies revealed that caspase-2 
is recruited to a high molecular weight 
complex distinct from the apoptosome 
in cell lysates upon transfer from 4°C 
to 37°C.7 During genotoxic stress, cas-
pase-2 has been shown to be recruited to a 
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multimeric protein complex, PIDDosome, 
constituting a Death Domain (DD)-
containing PIDD (P53-induced pro-
tein with death domain) and a DD and 
CARD domain-containing adaptor pro-
tein RAIDD (RIP-associated ICH-1/
CED-3 homologous protein with death 
domain).8 However, recent studies reveal 
that caspase-2 can be activated in the 
absence of PIDDosome, which warrants 
for the presence of additional caspase-2 
activation platforms.9 However, whether 
such caspase-2 complexes are formed in 
apoptotic cells and the unique apoptotic 
stimuli where caspase-2 is activated as an 
initiator caspase remain unclear.
By exploiting an “in situ caspase trap-
ping” approach employing biotin-VAD, 
we identified that caspase-2, but not cas-
pase-8 or caspase-9, is precipitated as a 
proximal caspase during PFT-mediated 
apoptosis in HeLa cells.3 Consistently, 
loss of caspase-2 prevented PFT-mediated 
apoptosis in HeLa cells and mouse embry-
onic fibroblasts. Interestingly, loss of either 
PIDD or RAIDD has failed to render pro-
tection to PFT-mediated apoptosis, and 
caspase-2 is activated in RAIDD-deficient 
cells. Caspase-2 is activated in caspase-3/7 
DKO MEFs, suggesting that the activa-
tion and processing of caspase-2 under 
these settings is independent of effector 
caspases.
Intriguingly, PFT-mediated cell death 
is partially inhibited by loss of Bax and 
Bak, the major regulators of the mito-
chondrial outer membrane permeabiliza-
tion or by the loss of effector caspases 3 
and 7 (Fig. 1). It is currently unclear how 
caspase-2 accomplishes Bax/Bak activa-
tion, and further, it is tempting to pro-
pose that caspase-2 might forgo the loss of 
these two effector caspases and cleave the 
relevant substrates directly to accomplish 
cell death (Fig. 1). Recent studies employ-
ing N-terminal COFRADIC (combined 
fractional diagonal chromatography) to 
study the degradome of caspases revealed 
that the protease specificities of caspase-2 
largely overlap with the effector caspases.10 
By applying Bimolecular Fluorescence 
Complementation (BiFc), we have 
checked for the intracellular localization 
of dimerized caspase-2-CARD domains 
in toxin-treated cells. Consistent with 
Bouchier-Hayes et al., we have detected 
a cytosolic staining of caspase-2-CARD-
BiFc signals in HeLa cells after treatment 
with α-toxin.3,11 The BiFc signals for cas-
pase-2-CARD domain exhibited a punc-
tuate staining under these settings.3
By employing high-resolution gel fil-
tration chromatography, we detected that 
caspase-2 is consistently detected in a high 
molecular weight fraction larger than a 
single ribosome (approx. 3 MDa) in the 
toxin-treated cells. This complex is devoid 
of RAIDD or PIDD, and we detect either 
the full-length or the processed fragments 
of caspase-2 in this high molecular weight 
complex in the apoptotic cells. Detection 
of full-length caspase-2 to this HMW 
complex suggests that caspase-2 is possibly 
recruited to this complex for its activation 
during PFT-mediated apoptosis in these 
cell types.
Previous studies revealed that PFTs 
induce K+ efflux in the cells, leading to 
various outcomes ranging from inflamma-
some activation to pyroptosis to autophagy 
depending on the cell type and the extent 
of the toxin insult (Fig. 1). As expected, 
inhibition of PFT-mediated K+ efflux pre-
vented the recruitment and activation of 
caspase-2 to the HMW complex, thus pre-
venting cell death. Further, physiological ©
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the activation of caspases-2 upon PFT 
treatment.5 In conclusion, our studies 
reveal unique apoptotic stimuli where cas-
pase-2 is activated as an initiator caspase to 
mediate apoptotic cell death in non-lym-
phoid cells. These observations possibly 
open up new avenues to decipher potential 
PIDDosome-independent caspase-2 acti-
vation platforms.
References
1.  Bischofberger M, et al. Curr Opin Cell Biol 2009; 
21:589-95; PMID:19442503; http://dx.doi.
org/10.1016/j.ceb.2009.04.003.
2.  Gonzalez MR, et al. Cell Mol Life Sci 2008; 65:493-
507; PMID:17989920; http://dx.doi.org/10.1007/
s00018-007-7434-y.
3.  Imre G, et al. EMBO J 2012; 31:2615-28; 
PMID:22531785; http://dx.doi.org/10.1038/
emboj.2012.93.
concentrations of K+ and Na+ ions have 
been shown to prevent the assemblage of 
apoptosome as well as the activation of 
caspase-2 in cell-free systems.7,12 Whether 
reduction in the physiological concen-
trations of K+ ions upon toxin treatment 
spontaneously led to the direct dimeriza-
tion of caspase-2 needs further studies. 
Further, it is currently unclear if there is 
a concurrent increase in the intracellular 
calcium ion concentrations upon toxin 
treatment, and if there is any role for Ca2+ 
influx in mediating caspase-2 activation in 
these cell types.
Interestingly, caspase-2 is regulated by 
phosphorylation under various settings, and 
it would be interesting to test if phosphor-
ylation/dephosphorylation events regulate 
Figure 1. Pore-forming toxins induce various forms of cell death depending on the cell type and the extent of toxin insult. in epithelial cells, caspase-2 
is activated as an initiator caspase in a Piddosome-independent manner to regulate PFt-mediated cell death. the PFt-mediated cell death is partially 
dependent on Bax and Bak as well as on effector caspases, revealing that caspase-2 might also exhibit features of effector caspases. activation of cas-
pase-2 has been shown to be regulated by PP1, 14-3-3 zeta and PKCK2 under various settings, and it would be interesting to characterize if caspases-2 
phosphorylation regulates its activation in response to PFts.